BERKELEY, Calif., March 10, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today appointed Mary L. Anderson as Vice President of Business Development. Ms. Anderson will oversee XOMA’s business development initiatives, including licensing activities related to XOMA’s therapeutic pipeline, support of the antibody collaborations business, the licensing of the company’s antibody technologies, and the advancement of biodefense programs.
